Tumor News and Research

RSS

Scientists develop new nanotechnology to capture, release tumor cells that circulate in bloodstream

Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.

17 Dec 2012

New technique could help develop more-specific, cell-based immune therapies for cancer

A team led by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, has shown for the first time the effectiveness of a new technique that could allow the development of more-specific, cell-based immune therapies for cancer.

17 Dec 2012

ASME 2nd Global Congress on Nano-engineering for Medicine and Biology to be held in Boston

The ASME (American Society of Mechanical Engineers) 2013 2nd Global Congress on Nano-engineering for Medicine and Biology (NEMB 2013) will be held Feb. 4-6, 2013, at the Renaissance Boston Waterfront Hotel in Boston, Mass.

17 Dec 2012

American Thoracic Society, IASLC and ERS propose new sub-classification of lung adenocarcinomas

The International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS), have proposed a new sub-classification of lung adenocarcinomas.

16 Dec 2012

Researchers identify 125 genetic components in temozolomide-resistant, GBM-derived cell line

University of Pittsburgh Cancer Institute (UPCI) researchers have identified over 125 genetic components in a chemotherapy-resistant, brain tumor-derived cell line, which could offer new hope for drug treatment to destroy the cancer cells.

15 Dec 2012

Study describes new, paradoxical characteristics of HER2-negative breast cancer

A multicenter study led by researchers at UC Davis describes new, paradoxical characteristics of the most common type of breast cancer. The findings shed light on how the disease can evade treatment and could improve diagnosis and treatment of breast cancer.

15 Dec 2012

Everolimus therapy might treat Myc-driven lymphoma

Drugs that are used in the clinic to treat some forms of breast and kidney cancer and that work by inhibiting the signaling molecule mTORC1 might have utility in treating some of the more than 15 percent of human cancers driven by alterations in the Myc gene, according to data from a preclinical study published in Cancer Discovery, a journal of the American Association for Cancer Research.

15 Dec 2012

Novartis receives FDA approval for Signifor injection to treat Cushing's disease

The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection for the treatment of Cushing's disease patients who cannot be helped through surgery.

15 Dec 2012

FDA approves Novartis Signifor injection for treatment of Cushing's disease

Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor (pasireotide) injection for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.

14 Dec 2012

Lyncean Technologies announces first sale of Compact Light Source

Palo Alto-based Lyncean Technologies, Inc., today announced its first sale of a Compact Light Source, a miniature synchrotron X-ray source employing state-of-the-art laser-beam and electron-beam technology.

14 Dec 2012

New technique may allow more kidney cancer patients to avoid conventional open surgery

Urologists at Henry Ford Hospital have developed a new technique that could make minimally invasive robotic partial nephrectomy procedures the norm, rather than the exception for kidney cancer patients. The technique spares the kidney, eliminates long hospital stays and provides better outcomes by giving the surgeon more time to perform the procedure.

14 Dec 2012

MicroRNA-218 especially low in medulloblastoma

Between the blueprint of the genome and the products of its expression lie microRNAs, which can boost or lower the rate at which genes become stuff. In fact, many cancers use microRNA to magnify the expression of faulty genes or shrink the expression of helpful genes that would otherwise suppress tumors. A University of Colorado Cancer Center study published in the December issue of the Journal of Biological Chemistry shows that in medulloblastoma, a malignant brain tumor of children, microRNA-218 is especially low.

14 Dec 2012

Researchers discover two-faced group of cells at work in human colon cancer

Northwestern Medicine researchers have discovered a "two-faced" group of cells at work in human colon cancer, with opposing functions that can suppress or promote tumor growth. These cells are a subset of T-regulatory (Treg) cells, known to suppress immune responses in healthy individuals.

14 Dec 2012

EZH2 protein enables advanced prostate cancers to spread without stimulation by male hormones

Scientists at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancer's growth. They say the finding could lead to a new treatment for prostate cancers that are no longer controlled by hormone-blocking drugs.

14 Dec 2012

Scientists isolate cancer stem cells that lead to growth of Wilms' tumours

Scientists have isolated cancer stem cells that lead to the growth of Wilms' tumours, a type of cancer typically found in the kidneys of young children. The researchers have used these cancer stem cells to test a new therapeutic approach that one day might be used to treat some of the more aggressive types of this disease.

13 Dec 2012

Champions Oncology operating revenues increase to $3.6M for six months ended October 31, 2012

Champions Oncology, Inc. (OTC: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today its financial results for the fiscal quarter ended October 31, 2012.

13 Dec 2012

Tumor News and Research

Scientists develop new nanotechnology to capture, release tumor cells that circulate in bloodstream

New technique could help develop more-specific, cell-based immune therapies for cancer

ASME 2nd Global Congress on Nano-engineering for Medicine and Biology to be held in Boston

American Thoracic Society, IASLC and ERS propose new sub-classification of lung adenocarcinomas

Researchers identify 125 genetic components in temozolomide-resistant, GBM-derived cell line

Study describes new, paradoxical characteristics of HER2-negative breast cancer

Everolimus therapy might treat Myc-driven lymphoma

Novartis receives FDA approval for Signifor injection to treat Cushing's disease

FDA approves Novartis Signifor injection for treatment of Cushing's disease

Lyncean Technologies announces first sale of Compact Light Source

New technique may allow more kidney cancer patients to avoid conventional open surgery

MicroRNA-218 especially low in medulloblastoma

Researchers discover two-faced group of cells at work in human colon cancer

EZH2 protein enables advanced prostate cancers to spread without stimulation by male hormones

Scientists isolate cancer stem cells that lead to growth of Wilms' tumours

Champions Oncology operating revenues increase to $3.6M for six months ended October 31, 2012

Breast cancer patients' recurrence fear distorted

Predictor of lymph node metastasis after oral cancer unmasked

Massage could ease distress of brain cancer

China SFDA approves Veridex’s CellSearch test for women with metastatic breast cancer

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News